It is a healthcare private limited company based in Pune, Maharashtra, India, established in 2016.
2016 | Pune, Maharashtra, India | ActiveAxsenta Pharmaceuticals Private Limited, a active private limited company, was established on 21 January 2016 in Pune, Maharashtra, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U74999PN2016PTC158041. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Arun Bandu Nanavare (Director), Shital Arun Nanaware (Director). Past directors included Arun Bandu Nanavare, Dattatraya Narayan Nanaware, Neel Arun Nanaware. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No 1, 999 Sadashiv Peth, Ambience 999, Pune, Maharashtra, 411030.
U74999PN2016PTC158041
158041
21 January 2016
₹1.00 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Axsenta Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Bandu Nanavare | Director | 26 Nov 2021 | Current |
| Shital Arun Nanaware | Director | 12 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 May 2019 | Past |
| Pramod Abcsdd | Director | 21 Jan 2016 | Past |
| Pramod Abcsdd | Director | 26 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 12 Feb 2018 | Past |
| Pramod Abcsdd | Director | 27 May 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axsenta Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1904.05% increase in profit. The company's net worth Soared by an impressive increase of 133.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Axsenta Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Axsenta Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Axsenta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axsenta Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Axsenta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Axsenta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Arun Bandu Nanavare was appointed as a Director was appointed as a Director on 26 Nov 2021 & has been associated with this company since 4 years 10 days . was recorded as a recent event.
The activity Shital Arun Nanaware was appointed as a Director was appointed as a Director on 12 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
Axsenta Pharmaceuticals Private Limited was registered on 21 Jan 2016 with Roc Pune & aged 9 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Axsenta Pharmaceuticals Private Limited is U74999PN2016PTC158041.
Axsenta Pharmaceuticals Private Limited is headquartered at Flat No 1, 999 Sadashiv Peth, Ambience 999, Pune, Maharashtra, 411030.
Axsenta Pharmaceuticals Private Limited was incorporated on 21 January 2016.
The current directors of Axsenta Pharmaceuticals Private Limited are
The primary industry of Axsenta Pharmaceuticals Private Limited is Hospital And Medical Care.
Axsenta Pharmaceuticals Private Limited is unlisted.
The authorized capital of Axsenta Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Axsenta Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX